𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Obstacles to the Development of a Neuroprotective Therapy for Parkinson's Disease

✍ Scribed by Stocchi, Fabrizio; Olanow, C. Warren

Book ID
121291478
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
120 KB
Volume
28
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Neuroprotective Therapy for Parkinson's
Neuroprotective Therapy for Parkinson's disease
✍ I.Shoulson and the Parkinson Study Group πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 103 KB πŸ‘ 1 views

In the context of degenerative disorders of the basal ganglia, neuroprotective therapy refers to interventions that preserve the integrity and function of vulnerable neurons and thereby slow or halt clinical decline. Decoppering therapy for Wilson's disease is the only established neuroprotective th

A rationale for monoamine oxidase inhibi
A rationale for monoamine oxidase inhibition as neuroprotective therapy for parkinson's disease
✍ Prof. C. W. Olanow πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 719 KB

Neurons in the substantia nigra may be vulnerable to oxidant stress because (a) the metabolism of dopamine generates peroxides. which, in the presence of iron. can lead to the formation of the highly reactive hydroxyl free radical; and (b) neuromelanin within nigral neurons can bind metals such as i